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Abstract
Background Peripapillary retinal nerve fiber layer (pRNFL)
and internal macular layer thinning have been demonstrated in
Alzheimer’s disease (AD) with optical coherence tomography
(OCT) studies. The purpose of this study is to compare the
pRNFL thickness and overall retinal thickness (RT) in AD
patients with non-AD patients, using spectral domain optical
coherence tomography (SD-OCT) and determine the sectors
most characteristically affected in AD.
Methods A cross-sectional study was performed to determine
the pRNFL and overall macular RT thicknesses in AD and
non-AD patients, attending a tertiary hospital center. For
pRNFL, the global and six peripapillary quadrants were cal-
culated, and for overall RT values, the nine Early Treatment
Diabetic Retinopathy Study (ETDRS) areas were used. A
multiple regression analysis was applied to assess the effects
of disease, age, gender, spherical equivalent, visual acuity,
intraocular pressure, axial length and blood pressure on
pRNFL and overall macular RT.
Results A total of 202 subjects, including 50 eyes of 50 pa-
tients with mild AD (mean age 73.10; SD = 5.36 years) and
152 eyes of 152 patients without AD (mean age 71.03; SD =
4.62 years). After Bonferroni correction, the pRNFL was sig-
nificantly thinner for the AD group globally and in the tem-
poral superior quadrant (10.76 μm and 20.09 μm mean de-
crease, respectively). The RT thickness was also decreased in
superior sectors S3 and S6 (mean thinning of 9.92 μm and
11.65 μm, respectively). Spearman’s correlation coefficient
showed a direct association between pRNFL in the temporal
superior quadrant and RT in superior S6 and S3 sectors (rS =
0.41; p < 0.001 and rS = 0.28; p < 0.001, respectively).
Conclusions Patients with AD showed a significant thickness
reduction in global and temporal superior quadrants in pRNFL
and in superior pericentral and peripheral sectors of RT. These
findings may reflect a peripapillary and retinal changes charac-
teristic of AD, suggesting the importance of SD-OCT as a po-
tential adjuvant in early diagnosis of AD. Further studies are
needed to understand which retinal layers and macular sectors
are more useful as potential ocular biomarker over time in AD.
Keywords Alzheimer’s disease . Spectral domain optical
coherence tomography . RNFL . Retina .Macula
Introduction
Alzheimer’s disease (AD) is the most common form of de-
mentia in elderly with great social impact [1]. Due to the
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increase in human life expectancy, the prevalence of AD is
also expected to follow the same trend and, consequently, the
need for early diagnosis emerges. The earliest AD pathologi-
cal change in the central nervous system is the accumulation
of amyloid β, derived from the abnormal processing of amy-
loid precursor protein [2]. This process can begin a decade
before the onset of the clinical syndrome of dementia. Visual
symptoms are also frequent among the earliest complaints in
AD patients, contributing to further impairment in the quality
of life [3, 4].
Hinton et al. first provided histopathological evidence of
optic neuropathy and degeneration of retinal ganglion cells
(RGCs) in patients with AD, with reduced number of RGCs
and reduced retinal nerve fiber layer (RNFL) thickness [5, 6].
Later post-mortem studies showed that degeneration of the
ganglion cell layer (GCL) occurs preferentially in superior
and inferior quadrants, as well as in the central retina, in par-
ticular, the temporal foveal region [7, 8].
In vivo studies of optic neuropathy in patients with AD
using fundus photographs showed RNFL and optic nerve
head abnormalities (increased cup-to-disc ratio and decreased
neuroretinal rim)[9–13], as well reduced macular thickness
and volume [14–23].
The present study aimed to identify the quadrants in which
peripapillary RNFL (pRNFL) and overall retinal thickness
(RT) changes were more pronounced in patients with AD,
using spectral domain optical coherence tomography (SD-
OCT). This study also took into account potential confound-
ing variables such as age, gender, spherical equivalent, best
corrected visual acuity (BCVA), axial length, intraocular pres-




This cross-sect ional study was conducted at the
Ophthalmology and Neurology Departments of the Central
Hospital Lisbon Center (CHLC), between October 2014 and
April 2016. Consecutive AD patients sent by the Neurology
Department for ophthalmological screening were observed for
inclusion/exclusion criteria. Patients with clinical criteria for
AD and mini-mental state examination (MMSE) scores be-
tween 21 and 26 were selected for the AD group (ADG) and
subjects without clinical criteria for dementia and MMSE
scores greater than 26 were included in the control group
(CG).
The inclusion criteria were AD patients between 65 and 78
years old with normotensive eyes, and ability to understand
the study.
Exclusion criteria were refractive error > 5 diopters (D) or/
and axial length > 25 mm in the studied eye; known diagnosis
of diabetes; retinal diseases; glaucoma or ocular hypertension;
uveitis; neurodegenerative diseases and significant media
opacities that precluded fundus imaging. Other relevant
known neurologic pathology, such as neurodegenerative dis-
eases, other types of dementia, previous stroke or uncertain or
indeterminate diagnosis was excluded.
The study protocol was approved by the local ethical com-
mittee, patient’s informed consent was obtained, and all the
procedures were performed in accordance with the revised
form of the Declaration of Helsinki (2008).
Fifty patients with mild AD (ADG) and 152 patients with-
out AD (CG) were recruited from the Neurology Department
of CHLC.
Study Procedures
After a pre-screening visit where demographic, background
history, full ophthalmological examination with visual acuity,
anterior segment examination, tonometry, indirect ophthal-
moscopy and ultrasonic biometry were recorded, patients
were assigned to a specific study visit where the following
methodology was taken: Goldmann applanation tonometry
and SD-OCT. Only the measurements of a randomly selected
eye of each subject were used.
Visual Acuity
BCVA for each eye was measured using Snellen charts and
converted to the logarithm of the minimum angle of resolution
(logMAR).
Intraocular pressure
IOP was measured before pupillary dilation with Goldmann
applanation tonometry and a mean of three measurements was
considered.
Spectral Domain Optical Coherence Tomography
Imaging
SD-OCT (Spectralis Heidelberg Engineering, Germany, soft-
ware version 6.0) was used for both eyes of each patient and
performed in the same visit for peripapillary and macular ob-
servations. For pRNFL measurements, three consecutive
scans were obtained using a circle size of 3.4 mm, at 2.6°
nasal and 2.1° superior off center. The software allows the
mapping of thicknesses for the seven peripapillary quadrants
(G - global, TS - temporal superior, T- temporal, TI - temporal
inferior, NI - nasal inferior, N - nasal, and NS - nasal superior)
according to Fig. 1.
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For macular measurements, subjects were studied
using the Bfast macular volume^ preset, consisting of a
25-line horizontal raster scan covering 20° × 20°, cen-
tered on the fovea (consisting of 25 high-resolution
scans). The overall RT values were calculated for the
nine Early Treatment Diabetic Retinopathy Study
(ETDRS) areas [24]. These ETDRS plots consist in
three concentric rings of 1-, 3- and 6-mm diameter cen-
tered at the fovea with the two outer rings subdivided
into four quadrants. Each sector was designated accord-
ing to Fig. 2, the fovea or central sector (C), the
pericentral ring (ETDRS sectors: S3, T3, I3 and N3)
and the peripheral ring (ETDRS sectors: S6, T6, I6
and N6).
The OCT images were obtained by one ophthalmologist
and were assessed by two other ophthalmologists, masked to
the patients’ diagnosis, who verified the automatic position of
the ETDRS grid, correcting when necessary.
Systolic and diastolic blood pressure
Blood pressure was measured in the seated position by an
automatic sphygmomanometer and systolic and diastolic
blood pressure (SBP and DBP) were recorded. Mean arterial
pressure (MAP) was calculated using the following formula:
MAP ¼ DBPþ 1=3 SBP–DBPð Þ
Statistical analysis
An exploratory analysis was carried out for all variables.
Categorical data were presented as frequencies (percentages),
and continuous variables as mean and standard deviation (SD)
or median and inter-quantile range (IQR: 25th percentile – 75th
percentile), as appropriate. Nonparametric chi-square tests and
Mann–Whitney tests were applied.
Linear regression models were used to identify the vari-
ables which may explain the variability of macular retinal
and pRNFL thicknesses. The variables group, gender, age,
IOP, axial length, spherical equivalent, MAP, BCVA, therapy
with diuretics and antihypertensive medication, were consid-
ered in this analysis. In the univariable regression analysis, all
the variables with a p value < 0.25 were selected for the mul-
tivariable models. Normality assumption of the residuals was
verified using Kolmogorov–Smirnov goodness-of-fit test with
Lilliefors correction.
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Fig. 1 Thickness of retinal nerve fiber layer obtained by BRNFL Single Exam Report OU with FoDi™^ (Spectralis Heidelberg; μm).
To study the association between pRNFL quadrant thick-
nesses and overall RT of each sector, Spearman’s correlation
coefficient (rS) was used.
A level of significance of α = 0.05 was considered. Data
were analyzed using the Statistical Package for the Social
Sciences for Windows (IBM Corp. released 2013. IBM
SPSS Statistics for Windows, Version 22.0. Armonk, NY:
IBM Corp.).
Results
Patient demographics and clinical characteristics
A total of 50 AD patients were included in the AD group and
152 patients without ADwere included in the CG. Concerning
gender, no significant differences were found between AD
and CGs (male 32.0% vs. 36.2%; p = 0.591). The mean age
was 73.1 (SD = 5.36) years in the AD group and 71.0 (SD =
4.62) years in the CG (p = 0.011).
The demographic, clinical and ophthalmologic characteris-
tics of the two groups, including BCVA, IOP, spherical
equivalent, axial length, MAP, therapy with diuretics and an-
tihypertensive medication, are summarized and compared in
Table 1.
OCT measurements of peripapillary retinal nerve fiber
layer
In a univariable analysis, the difference in thickness reached
statistical significance in all sectors with a thinning of the
pRNFL in the AD group compared with the CG (Table 2).
The remaining univariable regression models for pRNFL
thickness are presented in Supplemental Tables 1, 2 and 3.
In the multivariable linear regression models, after
adjusting for factors such as age, gender, visual acuity, IOP,
spherical equivalent, axial length, MAP, diuretic and antihy-
pertensive medication, we have observed a global thinning of
the pRNFL for the AD group in five of the seven peripapillary
quadrants, including the nasal quadrants (NI p = 0.004; N p =
0.004 and NS p = 0.004) and also G (p < 0.001) and TS (p <
0.001) quadrants (Table 3). The mean decrease of pRNFL in
the AD group when compared with the CG was between
6.927 μm and 20.089 μm. For each 10 years of increase of
life, the mean values of the TS quadrant also decreased
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Fig. 2 Comparison of macular thickness (μm) between control group and Alzheimer’s disease (AD) group at nine sectors. Results are expressed as
mean and standard deviation; p values were obtained by univariable linear regression models.
6.604 μm (95% CI: -12.475 to -0.734) (Table 3). Systolic
blood pressure also remained in the multivariable models for
nasal quadrants (NI p = 0.002; N p = 0.005 and NS p = 0.048)
and also G (p = 0.007), causing a mean thickening of the
quadrants between 2.00 μm and 4.89 μm, for each
10 mmHg of increase. After Bonferroni correction, the quad-
rants of pRNFL still statistically thinner for AD group were
localized in the G and TS quadrants (10.755-μm and
20.089-μm mean decrease, respectively).
Retinal macular thickness
The results of the univariable analysis showed that the RTwas
thinner in the AD group in eight of the nine sectors, between 1
and 6 mm centered at the fovea (Figure 2). The remaining
univariable regression models for RT are presented in
Supplemental Tables 4, 5 and 6.
In the multivariable linear regression models for seven RT
sectors (no multiple model was achieved for the N6 sector),
we observed a mean thinning in the AD group between
6.820 μm and 11.649 μm (p < 0.001 to 0.012). A mean thin-
ning between 4.714μmand 7.237μm for each 10 years of age
increase (p = 0.003 to 0.046) was also observed in the multi-
variable models for sectors T3, N3, S6, T6 and I6.
The results of the multivariable regression models after
Bonferroni correction showed two sectors still thinner with
statistical significance: the pericentral and peripheral superior
sectors S3 and S6 (mean thinning of 9.916 μm and 11.649
μm, with p = 0.001 and p < 0.001, respectively; Table 4).
Also, a mean thickening of 15.676 μm at the C sector in the
RT for male gender was observed (Table 4).
Finally, Spearman’s correlation coefficient showed a direct
association between pRNFLTS quadrant and RT S6 sector (rS
= 0.41; p < 0.001), stronger than the correlation between
pRNFLTS quadrant and RT S3 sector (rS = 0.28; p < 0.001).
Discussion
Regarding RNFL thinning in AD, it has been hypothesized
that the neuroretinal atrophy may occur as a result of amyloid
β plaque deposits within the retina [15] or as a result of retro-
grade degeneration of the RGC axons [17], and these changes
have been suggested to occur even before memory is affected
[18].
Since Parisi et al., pRNFL thinning has been demonstrated
with time domain OCT (TD-OCT); however, differences have
been reported regarding which peripapillary quadrants are
most affected using TD- and/or SD-OCT [15, 17, 18, 25].
Whether or not a correlation exists between retinal changes
and severity of dementia also remains a controversial issue.
While most studies concluded that OCT could be used to
detect early abnormalities in mild cognition impairment
(MCI) and AD, the majority reported no statistically signifi-
cant differences between MCI and AD patient groups [17,
26–29]. Only one TD-OCT study reported correlation
Table 1 Demographic and




Control group (n = 152) p value
Age (years) 73.1 (5.36) 71.0 (4.62) 0.011
Male gender n (%) 16 (32.0) 55 (36.2) 0.591*
BCVA (logMAR) 0.121 (0.153) 0.040 (0.073) <0.001
IOP - Goldmann (mmHg) 15.52 (2.62) 14.72 (2.51) 0.066
Spherical equivalent (D) 0.995 (1.43) 0.700 (1.64) 0.344
Axial length (mm) 22.44 (0.91) 22.49 (0.99) 0.668
Mean arterial pressure (mmHg) 98.91 (94.67–103.33) 97.87 (93.75–101.25) 0.287
Therapy with diuretics n (%) 14 (29.8) 26 (17.1) 0.058*
Antihypertensive medication n (%) 32 (64.0) 60 (39.5) 0.003*
Results are expressed as mean (SD) or median (IQR), as appropriate; best corrected visual acuity (BCVA); intra-
ocular pressure (IOP). *Chi-square test; remaining p values were obtained by Mann–Whitney tests.







Global 85.72 (14.42) 96.51 (9.36) <0.001
Temporal superior 108.20 (28.35) 129.59 (17.16) <0.001
Temporal 64.22 (13.01) 71.38 (12.66) 0.001
Temporal inferior 120.68 (23.69) 136.69 (20.06) <0.001
Nasal inferior 99.40 (25.95) 110.00 (22.22) 0.006
Nasal 68.76 (16.99) 74.77 (13.73) 0.012
Nasal superior 93.14 (29.08) 103.50 (17.45) 0.003
Results are expressed as mean (SD); p values were obtained by
univariable linear regression models.
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betweenMMSE scores and macular volume [14]. Also, meta-
analyses tried to determine the utility of OCT as a tool for
evaluating disease progression, and prognostic significance
of macular and RNFL thickness, but their conclusions failed
to determine a correlation between RNFL and the clinical
severity of dementia [30–34] .
In addition, one study using SD-OCT showed a diffuse re-
duction of the RNFL and ganglion cell layer combined in AD
[21] although the authors were not able to determinate which
layer was most affected by AD. Others studies have demon-
strated inner plexiform layer thinning in AD patients [14, 15,
21, 22, 35]. In a recent study analysing SD-OCT retinal
markers, including RNFL thickness, GCL thickness did not
show differences between AD patients age- and sex-matched
controls or other neurodegenerative diseases, but the authors
hypothesize that a larger sample would be necessary to delin-
eate significant differences between the groups studied [36].
In this study, we used SD-OCT to compare pRNFL thick-
ness and overall RT in mild AD patients with a large CG. In
the multivariable analysis, after adjustment for age, gender,
BCVA, IOP, axial length, spherical equivalent and MAP, the
global and temporal quadrants of pRNFL, and superior
pericentral and peripheral sectors of the overall retina were
thinner. Spearman’s coefficient showed a stronger correlation
between TS quadrant and S6 sector than between TS quadrant
and S3 sector. Our study shows that the classically described
macular asymmetry is confirmed only whenwe compare nasal
sectors with temporal ones.
After Bonferroni correction, the thinning was most pro-
nounced in the superiors sectors of RT (S3 and S6), with the
classically described superior/inferior asymmetry
disappearing. Our results are consistent with the visual field
findings reported by Trick et al. [37] and histopathological
findings of Armstrong [38]. They predominantly observed
inferior visual field defects and greater density of senile
plaques and neurofibrillary tangles in the cuneal gyrus than
in the lingual gyrus in patients with AD. The precuneus was
also described as particularly vulnerable for AD pathology,
including cerebral atrophy and amyloid deposition [39]. The
axons from the superior retina project via the parietal lobe
portion of the optic radiation to the cuneal gyrus of the prima-
ry visual cortex, and some authors found decreased longitudi-
nal functional connectivity between the precuneus and other
cerebral area networks in AD [40–42].
Our study had some limitations. The first one was the age
distribution of the two study groups that was corrected by the
linear regression models. Second, the automatic centration of
the ETDRS grid could have resulted in imprecise measure-
ments, but was confirmed by two independent ophthalmolo-
gists. Thirdly, although all participants were recruited from the
Neurology Department with clinical criteria and MMSE, no
amyloid markers (cerebrospinal fluid or amyloid imaging)
were used to increase the accuracy of the diagnosis.
Fourthly, as not all patients performed visual fields, the exclu-
sion of glaucomatous disease was based on IOP values and
indirect ophthalmoscopy. Lastly, like all cross-sectional
Table 3 Results of multivariable regression models - dependent variable: RNFL thickness
Model Coefficient estimate p value 95% Confidence interval
Dependent variable: RNFL thickness G
Alzheimer’s group* −10.755 <0.001 § −14.162 −7.349
Male gender −3.433 0.028 −6.485 −0.380
Systolic blood pressure 0.200 0.007 0.056 0.344
Dependent variable: RNFL thickness TS
Alzheimer’s group* −20.089 <0.001 § −26.710 −13.468
Age (years) −6.604 0.028 −12.475 −0.734
Dependent variable: RNFL thickness NI
Alzheimer’s group* −11.017 0.004 −18.398 −3.635
Male gender −7.393 0.029 −14.007 −0.778
Systolic blood pressure 0.489 0.002 0.177 0.801
Dependent variable: RNFL thickness N
Alzheimer’s group* −6.927 0.004 −11.643 −2.212
Age (years) 4.415 0.037 0.270 8.559
Systolic blood pressure 0.283 0.005 0.086 0.480
Dependent variable: RNFL thickness NS
Alzheimer’s group* −9.990 0.004 −16.774 −3.205
Systolic blood pressure 0.290 0.048 0.003 0.576
* Reference category: control group; age: for each increase of 10 years; p values were obtained by linear regression models. § with statistical significance
after Bonferroni correction.
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studies, it was not possible to draw conclusions about changes
in pRNFL and RT in a single individual over time. As only the
overall RT was considered, the atrophy of some retinal layers
may only be compensated by others in an attempt to fill/
compensate the possible functional and/or structural conse-
quences. In this sense, several studies showed that macular
GC-IPL thinning may be a more sensitive marker of earlier
neurodegeneration in MCI and AD than evaluation of the
overall RT [26–29]. The next step is to understand which
sectors of which layers can be earlier affected by AD and
the possible confounding factors associated with the thinning
of the layers.
Conclusion
Patients with AD showed a significant thickness reduction in
global and temporal quadrants in the pRNFL and in the
superior sector of the macula. This thinning may reflect a
peripapillary and retinal characteristic of AD, suggesting the
importance of SD-OCT as a potential adjuvant in early diag-
nosis of AD. Further studies are needed to understand which
retinal layers and macular sectors are more useful as potential
clinical ocular biomarkers for early detection of AD, and over
time in disease progression.
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